References
- Andrews W. C. Oral contraception. A review of reported physiological and pathological effects. Obstet Gynec Survey 1971; 26: 477–499
- Beck P. Metabolic effects of gonadal hormones and contraceptive steroids, H. A. Salhanic, D. M. Kipnis, R. L. van de Wiele. Plenum Press, New York and London 1969; 97
- Buchler D., Warren J. C. Effects of estrogens on glucose tolerance. Am J Obstet Gynec 1966; 95: 479–483
- Clinch J., Turnbull A. C., Khosla T. Effects of oral contraceptives on glucose tolerance. Lancet 1969; 1: 857–858
- Editorial. Metabolic effects of oral contraceptives. Lancet 1969; 11: 783–784
- Frerichs H., Grate S., Severidt E., Creutzfeldt W. 12 Symp. Deutsch. Ges. Endocrinologie. Wiesbaden 1966; 123–126
- Gershberg H., Javier Z., Hulse M. Glucose tolerance in women receiving an ovulatory suppressant. Diabetes 1964; 13: 378–382
- Goldman J. A., Eckerling B., Ovadia J. The effect of pseudopregnancy by ovulatory suppressants on the glucose tolerance in women. Fertil Steril 1969; 20: 393–399
- Hazzard W. R., Spiger M. J., Bagdade J. D., Bierman E. L. Studies on the mechanism of increased plasma triglyceride levels induced by oral contraceptives. New Engl J Med 1969; 280: 471–474
- Jarrett R. J., Graver H. J. Changes in oral glucose tolerance during the menstrual cycle. Brit Med J 1968; 11: 528–529
- Jung T. Kohlenhydrat und Fettstoffwechsel-Veränderungen während der Behandlung mit einem Ovulationshemmer. Thesis, Göttingen 1969
- Kannel W. B., Dawber T. R., Friedman G. D., Glennon W. E., McNamara P. N. Risk factors in coronary heart disease. Ann Intern Med 1964; 61: 888–899
- Pehrson S. L. Oral contraceptives and glucose tolerance. Acta Obstet Gynec Scand 1970; 49: 249–254
- Posner N. A., Silverstone F. A., Pomerance W., Baumgold D. Oral contraceptives and intravenous glucose tolerance. Obstet Gynec (NY) 1967; 29: 79–86
- Posner N. A., Silverstone F. A., Pomerance W., Singer N. Oral contraceptives and intravenous glucose tolerance. Obstet Gynec (NY) 1967; 29: 87–92
- Pyörälä K., Pyörälä T., Lampinen V. Sequential oral contraceptive treatment and intravenous glucose tolerance. Lancet 1967; 11: 776–777
- Spellacy W. N. A review of carbohydrate metabolism and the oral contraceptives. Am J Obstet Gynec 1969; 104: 448–460
- Spellacy W. N., Carlson K. L. Plasma insulin and blood glucose levels in patients taking oral contraceptives. Am J Obstet Gynec 1966; 95: 474–478
- Spellacy W. N., Carlson K. L., Birk S. A. Carbohydrate metabolic studies after six cycles of combined type oral contraceptive tablets. Diabetes 1967; 16: 590–594
- Spellacy W. N., Carlson K. L., Birk S. A., Schade S. L. Glucose and insulin alterations after one year of combination-type oral contraceptive treatment. Metabolism 1968; 17: 496–501
- Strup J., Date J., Deckert T. Serum insulin and intravenous glucose tolerance in oral contraception. Acta Endocr 1968; 58: 537–544
- Szabo A. J., Cole H. S., Grimaldi R. D. Glucose tolerance in gestional diabetic women during and after treatment with a combination-type oral contraceptive. New Engl J Med 1970; 252: 646–650
- Waine H., Frieden E. H., Caplan H. I., Cole T. Metabolic effects of Enovid in rheumatoid patients. Arthritis Rheum 1963; 6: 796
- Wynn V., Doar J. W. H. Some effects of oral contraceptives on carbohydrate metabolism. Lancet 1966; 11: 715–723
- Wynn V., Doar J. W. H. Some effects of oral contraceptives on carbohydrate metabolism. Lancet 1969; 11: 761–766
- Yen S. S. C., Vela P. Effects of contraceptive steroids on carbohydrate metabolism. J Clin Endocr 1968; 28: 1564–1570